v2.3.0.15
Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands
9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Operating activities  
Net income$ 6,982$ 7,920
Adjustments to reconcile net income to net cash provided by operating activities:  
Share-based compensation expense related to stock options and employee stock purchase plan3,8884,239
Excess tax benefit from exercise of stock options(2,729)(536)
Amortization of other purchased intangibles1,8272,245
Amortization of debt issuance cost216215
Depreciation1,5241,422
Change in valuation allowance on deferred tax assets1(1,548)
Impairment of intangible assets1,681 
Accretion/amortization on short-term debt securities(294)256
Realized gain on Auction Rate Securities (ARS) (1,934)
Realized loss on fair value of put option 1,921
Changes in operating assets and liabilities, net of acquired assets and assumed liabilities:  
Accounts receivable, net of allowances6,65014,343
Other current assets962,747
Accounts payable(388)(1,398)
Accrued compensation(1,329)522
Other accrued liabilities(363)(5,249)
Deferred tax assets, net of liabilities584649
Income taxes receivable(2,733)1,009
Income taxes payable5461,602
Other deferred liabilities(247)(280)
Restructuring liabilities(1,069)(1,570)
Deferred revenue(555)(7,559)
Net cash provided by operating activities14,28819,016
Investing activities  
Purchases of property and equipment(509)(703)
Proceeds from sale and maturity of investments59,36625,611
Purchases of short-term investments(33,176)(24,153)
Acquisition of Xenos Group Inc., net of cash acquired (27,343)
Proceeds from security deposits and other11535
Net cash provided by (used in) investing activities25,796(26,553)
Financing activities  
Repayment of long term debt(40,000) 
Proceeds from the Credit Facility, net of issuance cost 9,983
Excess tax benefit from exercise of stock options2,729536
Proceeds from issuance of common stock11,6984,565
Stock repurchases(4,999)(9,999)
Net cash provided by (used in) financing activities(30,572)5,085
Effect of exchange rates on cash and cash equivalents633920
Net increase/(decrease) in cash and cash equivalents10,145(1,532)
Cash and cash equivalents at the beginning of the period33,26953,173
Cash and cash equivalents at the end of the period$ 43,414$ 51,641